Eli Lilly News

Eli Lilly and Company today announced results from its non-clinical study in genetically engineered mice examining combination therapy with the murine version of the beta-amyloid antibody N3pG and beta-secretase inhibitor BACE .

Eli Lilly and Company has rebooted the Lilly for Better Health program, with several innovative enhancements to lillyforbetterhealth.com that help enrich the user experience with Lilly's non-product-branded health education.

On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: AbbVie upgraded to Overweight from Equal Weight at Barclays... Alcatel-Lucent upgraded to Overweight from Neutral at JPMorgan... BG Group upgraded to Buy from Hold at Canaccord... Baker Hughes upgraded to Neutral from Sell at Guggenheim... Bank of America upgraded to Buy from ... (more)

Eli Lilly and Company will announce its financial results for the second quarter of 2014 on Thursday, July 24, 2014.

Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.

Through its complaint made public on Tuesday in the U.S. District Court in Wilmington, DE, Sanofi is seeking to halt Lilly's proposed commercial marketing in the U.S. of a rival treatment, known as Abasria, saying the sale would violate its rights, Reuters noted.

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on diagnosis and management Lilly ... (more)

Eli Lilly and Company et al. v. Panacea Biotec, Ltd. 1:14-cv-01064; filed June 26, 2014 in the Southern District of Indiana Infringement of certain of U.S. Patent Nos.

Lilly's GKA has completed Phase 1 studies in the US in addition to extensive pre-clinical development.

A review committee of the European Medicines Agency has recommended approval of an investigational insulin compound developed jointly by Eli Lilly & Co.

The CHMP, Europe's equivalent of an FDA advisory committee that almost always gets its way, recently issues a slew of recommendations for the EU's health agency.

You will receive a download link right in your email inbox for each of the free reports that you choose.

This decision is important in the way that it confirms a strong Post- Ariad Written Description requirement - especially with regard to genus-species claim situations.

Pharmaceutical stocks like Eli Lilly , Merck and AbbVie had a great first half of 2014.

You will receive a download link right in your email inbox for each of the free reports that you choose.

Analysts at Deutsche Bank upgraded Bank of America from "hold" to "buy." The target price for Bank of America has been raised from $16.50 to $18.

Lantus is one of the world's best selling drugs, clocking $8 billion per year in revenue, and a cornerstone of Sanofi 's business.

Watch and find out the current strengths and weaknesses of Eli Lilly and if it should be ejected by investors.

KineMed Inc. could opt to withdraw its planned $41 million IPO after investors dissed the Emeryville biotech company's desired price.

Eli Lilly & Co. won European backing for a generic version of Sanofi's Lantus insulin, paving the way for the first copycat of the French drugmaker's top-selling medicine.